In the VMAP study, a noninvasive forward-solution computational ECG mapping system met accuracy goals for arrhythmia and pacing localization, suggesting a role for its use in targeted arrhythmia ...

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a partnership with HeartNexus, Inc., a ...

Austin, Texas, United States, October 28th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...

Please provide your email address to receive an email when new articles are posted on . Long-term continuous ECG monitoring with human oversight outperformed an artificial intelligence-based mobile ...

More than a decade after first earning the FDA’s sign-off for its Zio ECG patch, iRhythm is still churning out data to prove beyond a shadow of a doubt the heart monitor’s ability to spot atrial ...

Sarah Mitroff has worn many hats at CNET, including Senior Mobile Editor and Managing Editor of Health and Wellness. Currently, she is a freelance editor. Throughout her career, she's written about ...

We've read the fine print -- and consulted experts -- about Apple's irregular heart rhythm technology so you don’t have to. Danielle Kosecki is an award-winning journalist who has covered health and ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...